For help on how to get the results you want, see our search tips.
28 results
Categories
Human Remove Human filter
-
List item
Summary of opinion: Steglatro
ertugliflozin, opinion date: 16/09/2021, Positive, Last updated: 30/09/2021 -
List item
Summary of opinion: Lenvima
lenvatinib, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Kisplyx
lenvatinib, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Ultomiris
ravulizumab, opinion date: 22/07/2021, Positive, Last updated: 23/07/2021 -
List item
Summary of opinion: Elebrato Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Dengvaxia (new)
dengue tetravalent vaccine (live, attenuated), opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Epclusa (new)
sofosbuvir, velpatasvir, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Kaftrio (new)
ivacaftor, tezacaftor, elexacaftor, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Kalydeco (new)
ivacaftor, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Segluromet
ertugliflozin, metformin hydrochloride, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Temybric Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Trelegy Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Zepatier
elbasvir, grazoprevir, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Zeposia
ozanimod, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Xeljanz
tofacitinib, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Skyrizi
risankizumab, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Withdrawn application: Keytruda
pembrolizumab, date of withdrawal: 10/12/2019, Post-authorisation, Last updated: 19/03/2020 -
List item
Withdrawn application: Zydelig
idelalisib, date of withdrawal: 30/01/2018, Post-authorisation, Last updated: 23/02/2018 -
List item
Withdrawn application: Keytruda
pembrolizumab, date of withdrawal: 11/10/2017, Post-authorisation, Last updated: 28/11/2017 -
List item
Withdrawn application: Translarna
ataluren, date of withdrawal: 06/03/2017, Post-authorisation, Last updated: 24/03/2017 -
List item
Withdrawn application: Rienso
ferumoxytol, date of withdrawal: 19/01/2015, Post-authorisation, Last updated: 27/02/2015 -
List item
Withdrawn application: Revlimid
lenalidomide, date of withdrawal: 20/06/2012, Post-authorisation, Last updated: 06/07/2012 -
List item
Withdrawn application: Evoltra
clofarabine, date of withdrawal: 18/03/2008, Post-authorisation, Last updated: 19/03/2008 -
List item
Withdrawn application: Glivec
imatinib, date of withdrawal: 18/10/2006, Post-authorisation, Last updated: 23/10/2006 -
List item
Withdrawn application: Axumin
fluciclovine (18F), date of withdrawal: 11/02/2020, Post-authorisation, Last updated: 28/02/2020